239 related articles for article (PubMed ID: 23287123)
1. Immunohistochemical validation of TLE1, a novel marker, for synovial sarcomas.
Rekhi B; Basak R; Desai SB; Jambhekar NA
Indian J Med Res; 2012 Nov; 136(5):766-75. PubMed ID: 23287123
[TBL] [Abstract][Full Text] [Related]
2. Utility of characteristic 'Weak to Absent' INI1/SMARCB1/BAF47 expression in diagnosis of synovial sarcomas.
Rekhi B; Vogel U
APMIS; 2015 Jul; 123(7):618-28. PubMed ID: 25912315
[TBL] [Abstract][Full Text] [Related]
3. Specificity of TLE1 expression in unclassified high-grade sarcomas for the diagnosis of synovial sarcoma.
Valente AL; Tull J; Zhang S
Appl Immunohistochem Mol Morphol; 2013 Oct; 21(5):408-13. PubMed ID: 23197007
[TBL] [Abstract][Full Text] [Related]
4. Transducer-like enhancer of split 1 (TLE1) expression as a diagnostic immunohistochemical marker for synovial sarcoma and its association with morphological features.
Bakrin IH; Hussain FA; Tuan Sharif SE
Malays J Pathol; 2016 Aug; 38(2):117-22. PubMed ID: 27568668
[TBL] [Abstract][Full Text] [Related]
5. TLE1 is a robust diagnostic biomarker for synovial sarcomas and correlates with t(X;18): analysis of 319 cases.
Knösel T; Heretsch S; Altendorf-Hofmann A; Richter P; Katenkamp K; Katenkamp D; Berndt A; Petersen I
Eur J Cancer; 2010 Apr; 46(6):1170-6. PubMed ID: 20189377
[TBL] [Abstract][Full Text] [Related]
6. Tissue microarray based immunohistochemical study of TLE1 in synovial sarcoma and its histologic mimics.
Sivakoti S; Uppin SG; Uppin MS; Tara RP; Prayaga AK; Challa S
Indian J Pathol Microbiol; 2021; 64(2):310-315. PubMed ID: 33851625
[TBL] [Abstract][Full Text] [Related]
7. Expression of TLE1, INI1, β-catenin, Claudin1, CK7, CK19, SS18 and calponin in synovial sarcoma.
Madakshira MG; Radotra BD; Kaman L; Saikia UN
Indian J Pathol Microbiol; 2021; 64(4):707-716. PubMed ID: 34673590
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical staining for TLE1 distinguishes synovial sarcoma from histologic mimics.
Foo WC; Cruise MW; Wick MR; Hornick JL
Am J Clin Pathol; 2011 Jun; 135(6):839-44. PubMed ID: 21571956
[TBL] [Abstract][Full Text] [Related]
9. Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma.
Jagdis A; Rubin BP; Tubbs RR; Pacheco M; Nielsen TO
Am J Surg Pathol; 2009 Dec; 33(12):1743-51. PubMed ID: 19809272
[TBL] [Abstract][Full Text] [Related]
10. TLE1 expression is not specific for synovial sarcoma: a whole section study of 163 soft tissue and bone neoplasms.
Kosemehmetoglu K; Vrana JA; Folpe AL
Mod Pathol; 2009 Jul; 22(7):872-8. PubMed ID: 19363472
[TBL] [Abstract][Full Text] [Related]
11. TLE1 is expressed in the majority of primary pleuropulmonary synovial sarcomas.
Lino-Silva LS; Flores-Gutiérrez JP; Vilches-Cisneros N; Domínguez-Malagón HR
Virchows Arch; 2011 Dec; 459(6):615-21. PubMed ID: 22071579
[TBL] [Abstract][Full Text] [Related]
12. Transducer-like Enhancer of Split 1 as a Novel Immuno- histochemical Marker for Diagnosis of Synovial Sarcoma.
Atef A; Alrashidy M
Asian Pac J Cancer Prev; 2015; 16(15):6545-8. PubMed ID: 26434872
[TBL] [Abstract][Full Text] [Related]
13. Frequency of Transducer-like Enhancer of Split 1 Immunohistochemical Expression in Synovial Sarcoma: An Institution-based Cross-sectional Study.
Qureshi MB; Uddin N; Tariq MU; Raheem A; Pervez S
Cureus; 2019 Dec; 11(12):e6357. PubMed ID: 31938642
[TBL] [Abstract][Full Text] [Related]
14. Transducer-like enhancer of split 1 (TLE1) as a novel biomarker for diagnosis of synovial sarcoma correlates with translocation t(X;18): a study of 155 cases in China.
Li Y; Zhang X; Wang A; Ding S; Li Y; Wang H; Lv Y; Shi H
Int J Clin Exp Pathol; 2019; 12(1):251-258. PubMed ID: 31933740
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic utility of SOX10 to distinguish malignant peripheral nerve sheath tumor from synovial sarcoma, including intraneural synovial sarcoma.
Kang Y; Pekmezci M; Folpe AL; Ersen A; Horvai AE
Mod Pathol; 2014 Jan; 27(1):55-61. PubMed ID: 23929265
[TBL] [Abstract][Full Text] [Related]
16. BCOR-CCNB3-positive soft tissue sarcoma with round-cell and spindle-cell histology: a series of four cases highlighting the pitfall of mimicking poorly differentiated synovial sarcoma.
Li WS; Liao IC; Wen MC; Lan HH; Yu SC; Huang HY
Histopathology; 2016 Nov; 69(5):792-801. PubMed ID: 27228320
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Utility of TLE1 (Transducer-Like Enhancer of Split 1) in Distinguishing Synovial Sarcoma from Mimicking Tumors.
Qureshi MB; Tariq MU; Abdul-Ghafar J; Chundriger Q; Ud Din N
Int J Gen Med; 2021; 14():9173-9179. PubMed ID: 34880656
[TBL] [Abstract][Full Text] [Related]
18. Primary pleuropulmonary and mediastinal synovial sarcoma: a clinicopathologic and molecular study of 26 genetically confirmed cases in the largest institution of southwest China.
Lan T; Chen H; Xiong B; Zhou T; Peng R; Chen M; Ye F; Yao J; He X; Wang Y; Zhang H
Diagn Pathol; 2016 Jul; 11(1):62. PubMed ID: 27401493
[TBL] [Abstract][Full Text] [Related]
19. Expression of TLE1 in Malignant Melanoma With Spindle Cell Morphology: A Potential Diagnostic Pitfall.
Morrell TJ; Xiong Y; Deng A; Dresser K; O'Donnell P; Cornejo KM
Int J Surg Pathol; 2019 May; 27(3):259-262. PubMed ID: 30301396
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic utility of reduced immunohistochemical expression of SMARCB1 in synovial sarcomas: a validation study.
Ito J; Asano N; Kawai A; Yoshida A
Hum Pathol; 2016 Jan; 47(1):32-7. PubMed ID: 26520417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
